Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineNo recent work listed

Xuan Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1145-3155; OpenAlex author ID A5101627673. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2020: 3 papers · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 7

  1. Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer. Co-author DOI 10.1186/s12885-023-11239-w↗
  2. Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer. Co-author DOI 10.1002/jcla.24517↗
  3. Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.33410↗
  4. Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. Co-author DOI 10.3390/cancers13153678↗
  5. Cancer-associated fibroblasts in therapeutic resistance of pancreatic cancer: Present situation, predicaments, and perspectives. Co-author DOI 10.1016/j.bbcan.2020.188444↗
  6. Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective. Co-author DOI 10.1016/j.csbj.2020.11.018↗
  7. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway. Co-author DOI 10.1038/s41388-020-01407-8↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenquan Wang · 6 shared papers, 2020–2022 · strength 0.70
  2. Xianjun Yu · 6 shared papers, 2020–2022 · strength 0.70
  3. Heli Gao · 5 shared papers, 2020–2022 · strength 0.55
  4. Wuhu Zhang · 5 shared papers, 2020–2022 · strength 0.55
  5. Huaxiang Xu · 5 shared papers, 2020–2022 · strength 0.55
  6. Tianjiao Li · 4 shared papers, 2020–2022 · strength 0.45
  7. Liang Liu · 3 shared papers, 2020–2022 · strength 0.36
  8. Liang Liu · 3 shared papers, 2020–2021 · strength 0.34
  9. Hao Li · 3 shared papers, 2020–2021 · strength 0.31
  10. Shuo Li · 3 shared papers, 2020–2021 · strength 0.31
  11. Chuntao Wu · 3 shared papers, 2020–2021 · strength 0.31
  12. Xu Wang · 2 shared papers, 2021–2022 · strength 0.25
  13. Wang Jiang · 2 shared papers, 2020–2021 · strength 0.21
  14. Xuan Lin · 2 shared papers, 2020–2021 · strength 0.20
  15. Long‐Yun Ye · 2 shared papers, 2020–2021 · strength 0.20
  16. Zengya Guo · 1 shared paper, 2023 · strength 0.16
  17. Haitao Gu · 1 shared paper, 2023 · strength 0.16
  18. Chen Huang · 1 shared paper, 2023 · strength 0.16
  19. Peng Cao · 1 shared paper, 2023 · strength 0.16
  20. Yuhan Yang · 1 shared paper, 2023 · strength 0.16
  21. Zhengjun Qiu · 1 shared paper, 2023 · strength 0.16
  22. Jia Dong · 1 shared paper, 2021 · strength 0.10
  23. Zhenyu Liao · 1 shared paper, 2021 · strength 0.10
  24. Jiang Long · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.